SHANGHAI, Jan 30 (Reuters) - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company said on Friday, adding another participant to a hot sector in the ...

Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...

Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are ...

The Union Budget 2026 highlights India’s growing burden of diabetes, obesity and cancer. In her speech, Finance Minister ...

Diabetes is when your body has chronically elevated blood glucose levels due to either insulin insensitivity or lack of ...

By Tarun Sai Lomte From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why ...

Is your backside trying to tell you something? New research suggests that the shape of the GM — not just the size — could be ...

Around 12.1% of Black Americans have diabetes compared with about 6.9% of non-Hispanic White adults, according to the ...

The City of El Paso Department of Public Health (DPH) is offering free A1C testing to the community on “Take Charge Tuesdays” ...

Diabetes is a lifelong disease that affects almost 12% of people in the United States, according to the Centers for Disease Control and Prevention (CDC). Many of these people are often undiagnosed, ...

Alexander Zverev booked a third straight Australian Open semifinal on Tuesday, outlasting Learner Tien 6-3, 6-7(5), 6-1, ...